Zwitterionic phospholipids enhance aspirin's therapeutic activity, as demonstrated in rodent model systems1

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1221-1227

  Lichtenberger, Lenard M ^a   Ulloa, Carlos ^a   Vanous, Amy L ^a   Romero, Jim J ^a   Dial, Elizabeth J ^a   Illich, Paul A ^a   Walters, Edgar T ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMPHOLYTE; DIPALMITOYLPHOSPHATIDYLCHOLINE; PHOSPHOLIPID DERIVATIVE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG SCREENING; FEVER; INFLAMMATION; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; ASPIRIN; BODY TEMPERATURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION; MALE; PAIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030440981     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. ADAMS, S. S., HEBBORN, P. AND NICHOLSON, J. S.: Some aspects of the pharmacology of ibufenac, a non-steroidal anti-inflammatory agent. J. Pharm. Pharmacol. 20: 305-312, 1968.
2. ALLISON, M. C., HOWATSON, A. G., TORRANCE, C. J., LEE, F. D. AND RUSSELL, R. I.: Gastrointestinal damage associated with the use of non-steroidal anti-inflammatory drugs. N. Engl. J. Med. 327: 749-754, 1992.
3. BUTLER, B. D., LICHTENBERGER, L. M. AND HILLS, B. A.: Distribution of surfactants in the canine GI tract and their ability to lubricate. Am. J. Physiol. 244: G645-651, 1983.
4. CLARKE, G. D., MACPHERSON, I. S., PETRONE, G. AND SPANGLER, R. S.: Antinociceptive effects of non-steroidal anti-inflammatory drugs in a rat model of unilateral hindpaw inflammation. Eur. J. Pharmacol. 257: 103-108, 1994.
5. DAVIS, R. H., ROSENTHAL, K. Y., CESARIO, L. R. AND ROUW, G. A.: Processed Aloe vera administered topically inhibits inflammation. J. Amer. Pod. Med. Assoc. 79: 395-397, 1989.
6. DORGAN, C. A.: Statistical Records of Health and Medicine, Gale Research Inc., NY, 1995.
7. GAD, S. C., DUNN, B. J., DOBBS, D. W., REILLY, C. AND WALSH, R. D.: Development and validation of an alternative dermal sensitization test: The mouse ear swelling test. Toxicol. Appl. Pharmacol. 84: 93-114, 1986.
8. GIRAUD, M.-N. AND LICHTENBERGER, L. M.: Zwitterionic phospholipids facilitate the transport of aspirin across artificial membranes (Abstract). Gastroenterology 108: A101, 1995.
9. GLENN, E. M., BOWMAN, B. J. AND ROHLOFF, N. A.: Simple laboratory procedures for the evaluation of topically active anti-inflammatory drugs. Agents Actions 8: 497-503, 1978.
10. GODDARD, P. J.: Relationship between acid back-diffusion and luminal surface hydrophobicity in canine gastric mucosa: Effects of salicylate and prostaglandins. Thesis: The Univ. of Texas Health Science Center at Houston, Graduate School of Biomedical Sciences, 1989.
11. GODDARD, P. J., HILLS, B. A. AND LICHTENBERGER, L. M.: Does aspirin damage canine gastric mucosa by reducing its surface hydrophobicity? Am. J. Physiol. 252: G421-430, 1987.
12. GODDARD, P. J., KAO, Y.-C. J. AND LICHTENBERGER, L. M.: Luminal surface hydrophobicity of canine gastric mucosa is dependent on a surface mucus gel. Gastroenterology 98: 361-370, 1990.
13. GOGGIN, P. M., MARRERO, J. M., SPYCHAL, R. I., JACKSON, P. A., CORNBISHLEY, C. M. AND NORTHFIELD, T. C.: Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: Effect of clearance and eradication. Gastroenterology 103: 1486-1490, 1992.
14. HILLS, B. A., BUTLER, B. D. AND LICHTENBERGER, L. M.: Gastric mucosal barrier: The hydrophobic lining of the stomach. Am. J. Physiol. 244: G561-568, 1983.
15. IVEY, K. J. AND ROONEY, P. J.: Non-steroidal anti-inflammatory drugs and the gastrointestinal tract. Balliere's Clin. Rheum. 3: 393-409, 1989.
16. KAO, Y.-C., GODDARD, P. J. AND LICHTENBERGER, L. M.: Morphological effects of aspirin and prostaglandin on the canine gastric mucosal surface: Analysis with a phospholipid cytochemical stain. Gastroenterology 98: 592-606, 1990.
17. KAO, Y.-C. AND LICHTENBERGER, L. M.: Phospholipid- and neutral lipidcontaining organelles of rat gastroduodenal mucous cells. Gastroenterology 101: 7-21, 1991.
18. 2 on the lipidic organelles of rat gastric surface mucous cells. Gastroenterology 104: 103-113, 1993.
19. LICHTENBERGER, L. M.: The hydrophobic barrier properties of gastrointestinal mucus. Annu. Rev. Physiol. 57: 565-583, 1995.
20. LICHTENBERGER, L. M., GRAZIANI, L. A., DIAL, E. J., BUTLER, B. D. AND HILLS, B. A.: Role of surface-active phospholipids in gastric cytoprotection. Science (Wash. DC) 219: 1327-1329, 1983.
21. LICHTENBEBGER, L. M., WANG, Z.-M., GIRAUD, M.-N., ROMERO, J. J. AND BARRETO, J. C.: Effect of naproxen on gastric mucosal hydrophobicity (Abstract). Gastroenterology 108: A149, 1995a.
22. LICHTENBERGER, L. M., WANG, Z.-M., ROMERO, J. J., ULLOA, C., PEREZ, J. C., GIRAUD, M.-N. AND BARRETO, J. C.: Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nature Medicine 1: 154-158, 1995b.
23. MAUCH, F., BODE, G., DITSCHUNEIT, H. AND MALFERTHEINER, P.: Demonstration of a phospholipid-rich zone in human gastric epithelium damaged by Helicobacter pylori. Gastroenterology 105: 1698-1704, 1993.
24. NARDONE, G., D'ARMIETO, F., CORSO, G., COSCIONE, P., ESPOSITO, M. AND BUDILLON, G.: Lipids of human gastric mucosa: Effect of Helicobacter pylori infection and non-alcoholic cirrhosis. Gastroenterology 107: 362-368, 1994.
25. RAINSFORD, K. D.: Side-effects and toxicology of the salicylates. In Aspirin and the Salicylates, ed. by K. D. Rainsford, pp. 148-220, Butterworths, London, 1984.
26. RANDALL, L. O. AND SELITTO, J. J.: A method for measurement of analgesic activity of inflamed tissue. Arch. Int. Pharmacodyn. 111: 409-419, 1957.
27. SILVOSO, G. R., IVY, K. J. AND BUTT, J. H.: Incidence of gastric lesions in patients with rheumatoid arthritis on chronic aspirin therapy. Ann. Int. Med. 91: 517-520, 1979.
28. SLOMIANY, B. L., SAROSIEK, J. AND SLOMIANY, A.: Gastric mucus and mucosal barrier. Dig. Dis. Sci. 5: 125-145, 1987.
29. SLOMIANY, B. L. AND SLOMIANY, A.: Role of mucus in gastric mucosal protection. J. Physiol. Pharmacol. 42: 141-161, 1991.
30. SUZUKI, K., OTA, H., SASAGAWA, S., SAKATANI, T. AND FUJIKURA, T.: Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal. Biochem. 132: 345-352, 1983.
31. VANE, J. R. AND BOTTING, R. M.: Aspirin and Other Salicylates, Chapman and Hall Medical, London, 1992.